Related Experiment Video
Updated: May 11, 2026
05:58
Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
Published on: September 11, 2013
20.9K
Valsalva Retinopathy Presenting as Subretinal Hemorrhage
Lívia Conci1, Eliza Pereira1, Samia Navajas1
1Department of Ophthalmology, University of Sao Paulo, Sao Paulo, Brazil.
Case Reports in Ophthalmological Medicine
|May 8, 2024
Summary
Valsalva retinopathy can cause subretinal hemorrhage without prior eye disease. Surgical intervention with pars plana vitrectomy and subretinal tissue plasminogen activator injection led to good visual recovery.
Area of Science:
- Ophthalmology
- Retinal Diseases
Background:
- Subretinal hemorrhage can lead to significant vision loss.
- The Valsalva maneuver, often associated with strenuous exertion, can precipitate various ocular complications.
Observation:
- A 35-year-old male presented with sudden vision loss in his left eye following a vomiting episode.
- Fundus examination and optical coherence tomography (OCT) revealed submacular and preretinal hemorrhage.
- Angiography ruled out common causes of subretinal hemorrhage like macroaneurysms or neovascularization.
Findings:
- The patient underwent pars plana vitrectomy (PPV) with subretinal injection of tissue plasminogen activator (tPA) and air tamponade.
- The procedure successfully displaced the submacular hemorrhage.
- Best-corrected visual acuity improved from 20/200 to 20/30 within one month post-surgery.
Implications:
- Valsalva retinopathy is a rare but potential cause of subretinal hemorrhage, even in healthy individuals.
- Combined PPV and subretinal tPA injection can be an effective treatment for such cases, leading to favorable visual outcomes.
